You may also like
FDA Issues Public Health Advisory for Trasylol (Full Summary)
The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks and strokes in patients who undergo artery bypass graft surgery.
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
To determine the contemporary outcomes of surgical aortic valve replacement (SAVR) in a moderate surgical risk population.
The Year in Review: 2013
Circuit Surfers 2013 Editor’s Note: 2013 was a great year. Thank you all so very much for dropping in and participating in […]